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ABSTRACT
Protozoan parasites belonging to the family
Trypanosomatidae are characterized by an unusual
pathway for the production of mRNAs via poly-
cistronic transcription and trans-splicing of a
50 capped mini-exon which is linkedto the 30 cleavage
and polyadenylation of the upstream transcript.
However, little is known of the mechanism of protein
synthesis in these organisms, despite their impor-
tance as agents of a number of human diseases.
Here we have investigated the role of two
Trypanosoma brucei homologues of the translation
initiation factor eIF4A (in the light of subsequent
experiments these were named as TbEIF4AI and
TbEIF4AIII). eIF4A, a DEAD-box RNA helicase, is a
subunit of the translation initiation complex eIF4F
which binds to the cap structure of eukaryotic mRNA
andrecruitsthesmallribosomalsubunit.TbEIF4AIis
a very abundant predominantly cytoplasmic protein
(over1310
5molecules/cell)anddepletionto 10%of
normal levels through RNA interference dramatically
reduces protein synthesis one cell cycle following
double-stranded RNA induction and stops cell
proliferation.Incontrast,TbEIF4AIIIisanuclear,mod-
erately expressed protein ( 1–2 3 10
4 molecules/
cell), and its depletion stops cellular proliferation
after approximately four cell cycles. Ectopic expres-
sion of a dominant negative mutant of TbEIF4AI,
but not of TbEIF4AIII, induced a slow growth pheno-
type in transfected cells. Overall, our results suggest
that only TbEIF4AI is involved in protein synthesis
while the properties and sequence of TbEIF4AIII indi-
cate that it may be the orthologue of eIF4AIII, a
component of the exon junction complex in
mammalian cells.
INTRODUCTION
The ﬂagellate protozoan parasites belonging to the family
Trypanosomatidae include a number of important pathogens
responsible for diseases of worldwide impact such as the
Sleeping Sickness (Trypanosoma brucei), Chagas’ Disease
(Trypanosoma cruzi) and the various forms of Leishmaniasis
(Leishmania sp.) (www.who.int/tdr). These organisms are
unusual in a number of processes necessary for mRNA syn-
thesis and maturation; transcription is polycistronic and mono-
cistronic mRNAs arise after trans-splicing of a capped short
exon on to the 50 end and cleavage and polyadenylation at the
30 end [reviewed in (1,2)]. As a result of trans-splicing, the
50 ends of mature trypanosomatid mRNAs all share the same
39 nt leader sequence with a modiﬁed cap 4 structure (3). To
date, little is known about how these mRNAs are translated, if
major differences exist within the process of protein synthesis
when compared with other eukaryotes and whether the com-
mon leader sequence inﬂuences how the mRNAs are recruited
for translation.
In eukaryotes, protein synthesis is a complex process
which requires a myriad of different macromolecules
including RNAs and proteins. The critical initiation step
requires a number of translation initiation factors (eIFs)
whose activity can be highly regulated [for reviews see
(4–7)]. Paramount within these factors is the heterotrimeric
eIF4F complex, which is required for the recruitment of
the small ribosomal subunit to the 50 end of the mRNA.
eIF4F is composed of the RNA helicase eIF4A, the cap-
binding protein eIF4E and the large scaffolding protein
eIF4G which mediates interactions between eIF4F and
other translation factors as well as the small ribosomal subunit
[reviewed in (8)].
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RNA helicases which includes several proteins mainly
involved in RNA metabolism. These proteins are classiﬁed
within the superfamily II of a much larger group of related
RNA and DNA helicases (9). The RNA helicases couple the
hydrolysis of ATP to various activities relevant for RNA func-
tion such as rearrangement of inter- or intra-molecular RNA
structures, dissociation of RNA–protein complexes and RNA
unwinding. The DEAD-box family members are characterized
by nine sequence motifs (I, Ia, Ib, II, III, IV, V and VI and the
Q motif), as well as several individual amino acids, conserved
among the various proteins assigned to this family [for reviews
see (10,11)]. Structurally, eIF4A assumes a ‘dumbbell’ shape
with two globular domains connected by a ﬂexible linker (12).
Comparison with the structure of related RNA and DNA heli-
cases and the Methanococcus jannaschii DEAD-box protein,
similar in size to eIF4A (13), have conﬁrmed the basic overall
structure of the core helicase domains. The various conserved
motifs are positioned in the interface between the two domains
and have been implicated in RNA binding and ATP binding
and hydrolysis. However, little is known about the molecular
basis for RNA speciﬁcity and helicase function [reviewed in
(11,14)]. In translation initiation, eIF4A binds to the central
region of eIF4G, via the eIF4G HEAT domain (15) and, in
mammalsatleast,alsototheeIF4GC-terminus(16,17).eIF4A
seems to be responsible for melting secondary structures along
the mRNA 50-untranslated region (50-UTR), facilitating the
binding of the small ribosomal subunit and the scanning of
the leader region to locate the initiation codon (18,19)
[reviewed in (4,6)].
In mammals three different isoforms of eIF4A have been
described. Both eIF4AI and II (90% identity between the two
proteins) are able to reconstitute the eIF4F subunit and pre-
sumably have similar roles in translation (20,21). In contrast,
eIF4AIII, only 66% identical to mammalian eIF4AI, is func-
tionally distinct. While eIF4AIII exhibits RNA-dependent
ATPase activity and ATP-dependent RNA helicase activity,
it does not support binding of the small ribosomal subunit to
the mRNA, and inhibits translation in vitro (22). eIF4AIII
localizes to the nucleus (23) and recent reports indicate that
it may act asananchoringfactor forthe exonjunctioncomplex
(EJC), and is essential for nonsense-mediated decay (NMD) in
mammals (24–30).
The mechanisms of translation initiation are virtually
unknown in trypanosomatids. A Leishmania eIF4A homo-
logue (called LeiF) was ﬁrst described in Leishmania
braziliensis and Leishmania major as a 45.3 kDa antigen,
expressed in both insect and mammalian stages of the parasite
life cycle, but its role in translation was not investigated
(31,32). Recently, our group has identiﬁed multiple L.major
homologues for the three eIF4F subunits, all of which are
conserved in T.brucei (33). We characterized two putative
L.major eIF4A homologues, LmEIF4A1 (LeiF) and
LmEIF4A2, with 59 and 52% identities to human eIF4AI,
respectively. When assayed with isoform speciﬁc antibodies
these two factors differ signiﬁcantly in abundance in L.major
promastigotes. LmEIF4A1 is very abundant with over
10
5 molecules/cell whilst LmEIF4A2 is either absent or pre-
sent at levels below 10
4 molecules/cell. Furthermore, only
LmEIF4A1 was found to bind speciﬁcally to the HEAT
domain of one of the Leishmania eIF4G homologues (33).
In this paper we take advantage of the genetic tools available
for the study of gene function in T.brucei to extend this analysis
of the two trypanosomatid eIF4A homologues. Initially, the
mRNA and protein levels of the two T.brucei eIF4A ortho-
logues were analysed during the life cycle. Their intracellular
localization was identiﬁed through overexpression of enhanced
yellow ﬂuorescent protein (EYFP) fusions and their role for
parasite viability investigated through RNA interference and
overexpression of dominant negative mutants. Our results
show that the T.brucei orthologue of LmEIF4A1 (named as
TbEIF4AI) is the functional homologue of the eIF4A present
ineIF4F. Asfor theorthologueofLmEIF4A2,it seems tobethe
functional homologue of the nuclear eIF4AIII present in higher
eukaryotes and has been named here as TbEIF4AIII.
MATERIALS AND METHODS
Sequence analysis and molecular modeling
BLAST searches were carried out with the T.brucei genome
sequences available at the Gene DB website of the Sanger
Institute Pathogen Sequencing Unit (www.genedb.org). Fur-
ther sequence searches, Clustal W alignments and molecular
modeling were done as described previously (33).
PCR and cloning methods
The TbEIF4AI coding sequence was ampliﬁed from T.brucei
Lister 427 genomic DNA (50primer, AAG CTT CCG CCA
CCA TGG CCC AAC AAG GAA AG; and 30primer, GGA
TCC AGA ACC CTC ACC AAG GTA GGC AGC; added
restriction sites used in cloning are underlined) resulting in
the entire open reading frame (ORF) ﬂanked by sites for the
enzymes HindIII and BamHI. The same strategy was used for
the ampliﬁcation of the TbEIF4AIII sequence (50primer, AAG
CTT CCG CCA CCA TGA CAG CAA CCG CAA GG; and
30primer, GGA TCC AGA ACC GAA CTG TTC ACC GAC
GTT TG). The ampliﬁed fragments were then cloned into the
vector pGEM-T Easy (Promega) and sequenced. In order to
express N-terminal His-tagged fusion proteins both fragments
were then recovered by digestion with HindIII and BamHI and
subcloned into the same sites of a modiﬁed pET15b vector. To
generate the TbEIF4AI-EYFP and TbEIF4AIII-EYFP con-
structs, the two eIF4A fragments were cloned into the HindIII
and BamHI sites of p2215, a modiﬁed form of pLEW82 (34).
To make p2215, the EYFP ORF (Clontech) was obtained as a
BamHI/BglII fragment and inserted into the BamHI site of
pLEW82. On expression, the resultant fusion protein had the
sequence: eIF4A C-terminal residue-GSGSGGG-EYFP. For
the RNAi experiments the same two eIF4A DNA fragments
were also subcloned into the HindIII/BamHI sites of the trans-
fection vector p2T7-177 (35). Dominant negative mutants were
made by altering the sequence of the DEAD box of the helicase
(motif II in Figure 1) to DQAD (11,36). Tetracycline-inducible
expression of wild type and dominant negative forms of eIF4A
was performed using p2280, a derivative of pLEW100 made by
introducing a BamHI/BglII DNA segment encoding three tan-
dem myc epitope tags to its BamHI site. The two HindIII/
BamHI T.brucei eIF4A fragments were cloned into the same
sites ofp2280 resulting intheexpressionoffusion proteinswith
the myc epitope tags on their C-terminus giving the sequence
2496 Nucleic Acids Research, 2006, Vol. 34, No. 9eIF4A-GSGSGPREQKLISEEDLPREQKLISEEDLPREQK-
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Parasite growth, transfection and RNAi
Procyclic form T.brucei Lister 427 cells were used throughout.
RNAi and ectopic expression of eIF4A were performed using
T.brucei Lister 427 29-13, containing integrated copies of
pLEW 29 and pLEW13 (34). Procyclic T.brucei forms
were propagated in SDM-79 medium at 27 C, supplemented
with 10% feotal calf serum (FCS). For the 29–13 cell line,
cultures were also supplemented with G418 (15 mg/ml) and
hygromycin (25 mg/ml). Parasite growth was monitored
microscopically every 24 h. Mid-log phase cultures (10
6–
10
7 cells/ml) were then used for transfection and total protein
extract production. Bloodstream forms (Lister 427) were
cultivated in HMI-9 medium (37) at 37 C, 5% CO2, supple-
mented with 10% FCS. Cultures grown to mid-log phase
cultures (10
5–10
6 cells/ml) were also harvested for the pro-
duction of total protein extract.
Plasmids were linearized with NotI prior to electroporation
and stable DNA integration was selected using phleomycin
(2.5 mg/ml). For the RNAi experiments 1 mg/ml of tetracycline
was added to mid-log phase cultures of transfected cells.
RNA analysis
RNA extraction and Northern blots were performed using
standard methods (38,39). DNA fragments containing com-
plete ORFs were used as probes for TbEIF4As and EP pro-
cyclin. A genomic repeat containing both a- and b-tubulin
genes was used to detect tubulin mRNA.
Recombinant protein expression, antibody production
and western blots
His-tagged TbEIF4AI and TbEIF4AIII were expressed in
Escherichia coli BL21 Star (DE3) using pET15b derived plas-
mids. The recombinant polypeptides were insoluble after lys-
ing the cells using a French Press. The polypeptides were
puriﬁed by preparative SDS–PAGE and the bands correspond-
ing to the recombinant proteins were then excised and sent for
the production of polyclonal serum (CovalAb). Prior to their
use, both antibodies were ﬁrst afﬁnity puriﬁed as described
elsewhere (40) with their respective recombinant proteins.
Cross-reacting antibodies were eliminated by previous
incubation of the anti-TbEIF4AI antisera with TbEIF4AIII
recombinant protein and vice versa. To estimate the levels
of the eIF4A proteins, ﬁrst the recombinant proteins were
quantiﬁed by serial dilutions in SDS–PAGE by comparison
Figure1.SequencealignmentcomparingtheT.brucei,T.cruziandL.majoreIF4Ahomologues.SequenceswerealignedwiththeClustalWprogram,fromtheCentre
forMolecularandBiomolecularInformatics(http://www.cmbi.kun.nl/bioinf/tools/clustalw.shtml).Aminoacidsidenticalin>60%ofthesequencesarehighlighted
in dark gray, while amino acids defined as similar, based on the BLOSUM 62 Matrix, on >60% of the sequences, are shown in pale gray. When necessary, gaps
were inserted within the various sequences (dashes) to allow better alignment. The nine motifs typical of DEAD-box RNA helicases (10,11) are highlighted.
The single arrows indicate other individual amino acids which seems to be relevant for eIF4A function or RNA binding (12,42). Relevant GenBank accession
numbers: LmEIF4AI, AAC24684/AAC24685; LmEIF4AIII, CAJ05468; TbEIF4AI, EAN76544; TbEIF4AIII, EAN79829; TcEIF4AI, EAN98527; TcEIF4AIII,
EAN88971.
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quantiﬁcation they were then used in western blots with the
respective antisera and compared with serial dilutions of total
protein extract from both procyclic and bloodstream forms of
T.brucei. The endogenous protein levels were then estimated
by the densitometric analysis of the western blot results as
described elsewhere (33).
Fluorescence microscopy
For the indirect immunoﬂuorescence assay, wild-type pro-
cyclic cells grown to mid-log phase (5 · 10
6/ml) were har-
vested, washed with phosphate-buffered saline (PBS)/10 mM
glucose and adsorbed to polylysine coated slides. The cells
were then ﬁxed in 100% methanol at  20 C/15 min. Antibody
detection of TbEIF4AI and III followed standard procedures.
DNA was stained using Hoechst 33258. For the analysis of the
cells expressing TbEIF4AI-EYFP and TbEIF4AIII-EYFP, ali-
quots of 5 · 10
6 cells were harvested, washed with PBS/10
mM glucose and ﬁxed in 0.1% formaldehyde for 5 min. In this
case, DNA was stained using Hoechst 33342.
Metabolic labelling
To measure the rate of protein synthesis, [
35S]methionine
(10 mCi/ml) was added to mid-log cultures which were
incubated for 1 h prior to the determination of trichloroacetic
acid precipitable incorporation into protein. Parallel incuba-
tions in the presence of 50 mg/ml cycloheximide were used to
estimate incorporation of radiolabel by processes other than
cytoplasmic proteinsynthesis. For metabolic labeling, cultures
were washed twice with methionine-free RPMI 1640 medium
and then resuspended at 1 · 10
7 cells/ml in methionine-free
RPMI 1640 containing 50 mCi/ml [
35S]methionine and incu-
bated for 1 h at 28 C prior to harvesting and analysis by
SDS–PAGE and autoradiography.
RESULTS
Identification of the T.brucei eIF4A homologues
The T.brucei homologues of eIF4A were identiﬁed in searches
of the genome sequence using human eIF4AI as well as the
two Leishmania eIF4A sequences. At the amino acid level, the
two T.brucei proteins, TbEIF4AI and TbEIF4AIII, are very
similar to their L.major orthologues with identities of 88% for
the eIF4AI and 82% for the eIF4AIII pair (to avoid confusion
and in view of the data presented below the L.major eIF4A
homologues, previously called LmEIF4A1 and 2, have also
been renamed to LmEIF4AI and LmEIF4AIII and this nomen-
clature will be used when needed). The assignment as eIF4A
homologues reﬂects the fact that the two sequences are the
closest matches in the two parasite protein databases to human
eIF4AI and both share identities of over 50% with the human
protein. The third nearest eIF4A homologue in both T. brucei
and L. major databases has been assigned to another group of
RNA helicases, Dhh1 (33), with an identity of only  40% to
human eIF4AI. In order to analyse the conservation of the
putative eIF4A homologues within an additional member of
the family Trypanosomatidae, we performed similar searches
using the T.cruzi genome database. Again, orthologues to both
proteins could be found in T.cruzi with the third nearest match
to human eIF4AI being Dhh1.
Figure 1 shows a sequence alignment comparing the two
eIF4A sequences from T.brucei with those from T.cruzi and
L.major. Highlighted in the ﬁgure are the various conserved
motifs typical of eIF4A and related proteins which have been
shown to be required for different aspects of the RNA helicase
activity.MotifsI,II,VIandtherecently identiﬁedQmotif(41)
have been implicated in ATP binding and hydrolysis; motif III
may link nucleotide hydrolysis to helicase function; motifs Ia,
Ib, IV and V may be involved in RNA binding [reviewed in
(11,14)]. Several conserved arginine residues, which have also
been implicated as important for eIF4A/helicase function in
yeast eIF4A (12), as well as a conserved N-terminal pheny-
lalanine residue are also shown (42). Overall the alignment
conﬁrms the close similarity between the various homologues.
In general the N-terminal half of the protein is less conserved
than the C-terminal half but only in the very N-terminus are
signiﬁcant differences in the sequences observed. A few con-
served differences between the three eIF4AI and three
eIF4AIII homologues with potential signiﬁcance for their
function can be identiﬁed, such as the replacement of a con-
served F46 E47 doublet withinthe Q motif of eIF4AI by YK in
eIF4AIII proteins. Other individual substitutions conserved
between the eIF4AI and eIF4AIII homologues can be seen
within motifs Q (S50T, S51A), I (Q71S), IV (A275C), V
(V328W) and VI (G359T). So far however the functional
signiﬁcance of these substitutions is unknown.
ExpressionofTbEIF4AmRNAsinT.bruceibloodstream
and procyclic forms
To begin the functional characterization of T.brucei eIF4A
homologues and assay their expression at the mRNA level,
the two genes were ampliﬁed, cloned and used as probes in
northern blots of RNA from T.brucei procyclic and blood-
stream forms (Figure 2A). The membranes were also probed
for the constitutively expressed tubulin, to conﬁrm that equal
amounts of mRNA were loaded in each lane, and for the
procyclic-speciﬁc EP procyclin mRNA to verify the stage
speciﬁcity of both sets of mRNAs (43).
The two T.brucei eIF4A mRNAs were readily detected and
foundtobeatconstantlevelsthroughouttheparasitelifecycle.
However,accordingtothe northernblot,the TbEIF4AImRNA
produces a much stronger signal than TbEIF4AIII. Since both
probes usedwere ofsimilar speciﬁc activity,and the exposures
times for the ﬁlms were similar as well, it seems that the
TbEIF4AIII mRNA is far less abundant than TbEIF4AI.
Remarkably, although the ORFs for both proteins are similar,
1215 versus 1206 bp for TbEIF4AI and TbEIF4AIII, respec-
tively, their mRNAs differ signiﬁcantly, with the TbEIF4AI
message, at  3 kb, being nearly twice the length of TbEI-
F4AIII ( 1.6 kb), probably reﬂecting a considerable dif-
ference in the length of the 30-UTR.
TbEIF4AI is about 10-fold more abundant than
TbEIF4AIII in both procyclic and bloodstream forms
Recombinant His-TbEIF4AI and III were expressed in E.coli,
puriﬁed from inclusion bodies and used to produce antisera.
Afﬁnity puriﬁcation and depletion was used to produce spe-
ciﬁc antibodies for each protein (see below, Figure 6A). The
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expression of both proteins as well as to estimate their intra-
cellular levels. TbEIF4AI is very abundant (Figure 2B) and
although the quantiﬁcation is only approximate, its levels were
estimated at  2–5 · 10
5 and 0.8–1.5 · 10
5 molecules/cell in
procyclic and bloodstream forms, respectively, this difference
being a reﬂection of the relative volumes of the two cell types.
These levels are compatible with what has been observed with
the L.major orthologue (33) as well as yeast eIF4A (44). In
contrast, TbEIF4AIII levels were estimated at  2 · 10
4 and
1 · 10
4 molecules/cell in procyclic and bloodstream forms,
respectively (Figure 2B). These data indicate that TbEIF4AI is
present at levels at least 10-fold higher than TbEIF4AIII, a
difference which is reminiscent of the situation with the
L.major orthologues (33). Since there are estimated to be
 50 000 mRNAs per procyclic cell (Supplementary Data),
TbEIF4AI is in excess relative to mRNA, in contrast to TbEI-
F4AIII. Overall we conclude that both proteins are expressed
constitutively and that only the TbEIF4AI levels are compati-
ble with a role in translation.
Subcellular localization of TbEIF4AI and III
To determine the subcellular localization of the T.brucei
eIF4A homologues we used two different experimental
approaches. First the TbEIF4AI and TbEIF4AIII ORFs were
cloned into the vector p2215 and the construct integrated into
the non-transcribed spacer of a ribosomal RNA gene locus in
the procyclic cell line Lister 427 29-13. This resulted in a
tetracycline-inducible transgene encoding the eIF4A fused
at the C-terminus to EYFP. Expression of both constructs
was ﬁrst veriﬁed by western blotting and similar levels of
expression were observed for both TbEIF4AI and III-EYFP
fusion proteins (data not shown). The ﬂuorescent proteins
were visualized by microscopy (Figure 3) and strikingly,
the two proteins localize differentially within cells. TbEI-
F4AI-EYFP is found predominantly in the cytoplasm, whilst
TbEIF4AIII-EYFP is only found in the nucleus. These results
were conﬁrmed for the endogenous proteins through indirect
immunoﬂuorescence using isoform speciﬁc antibodies: again
TbEIF4AI was mainly found in the cytoplasm whilst TbEI-
F4AIII was only detected in the nucleus (Figure 3).
RNAi of TbEIF4AI and TbEIF4AIII
The function of the two eIF4A homologues was then inves-
tigated by knock down of expression through RNA interfer-
ence. First, both ORFs were subcloned into the vector
p2T7-177 vector (35) and the constructs integrated into the
procyclic cell line Lister 427 29-13 resulting in cell lines with
tetracycline-inducible expression of double-stranded RNA.
Cell proliferation was reduced within 24 h and ceased
around 48 h after induction of TbEIF4AI RNAi (Figure 4A)
and the cell density increased by  3-fold during this time.
Western blotting over a time course after addition of tetracy-
cline showed that the level of the protein decreased to <10% of
the starting level but expression was not completely ablated
(Figure 4B). Protein synthesis after induction of TbEIF4AI
RNAi was monitored in two ways: (i) metabolic labelling
to identify any alterations in the complement of polypeptides
synthesized, and (ii) the rate of total protein synthesis was
measured. There were no substantial changes in the proﬁle
of proteins synthesized although a small number of polypep-
tides appear to be relatively less affected by TbEIF4AI deple-
tion. The overall rate ofprotein synthesis had halved by  22 h,
the time at which cell proliferation ceased and was reduced to
<20% of the uninduced control by 48 h as shown in Figure 4C.
Figure 2. Expression analysis of TbEIF4AI and III. (A) Total RNA from both
procyclic (PCF) and bloodstream (BSF) T.brucei forms was separated on de-
naturing gels and used in northern blot assays to detect the expression of
TbEIF4AI and III. One of the blots was overprobed with tubulin (ubiquitously
expressed) and EP procyclin (expressed in procyclics only) as controls. The
migration of RNA size markers is indicated on the left in kilobases. (B) Quan-
tificationofTbEIF4AIandTbEIF4AIIIintheprocyclicandbloodstreamforms
ofT.brucei.RecombinantHis-taggedTbEIF4AIandIIIwerequantified,diluted
to defined concentrations (in fmol) and ran on SDS–PAGE gels with whole
parasite extract obtained from known number of cells from both procyclic and
bloodstreamforms(1.25·10
4–2·10
5forTbEIF4AIand1.25·10
5–2·10
6for
TbEIF4AIII). The proteins samples were then transferred to Immobilon-P
membranes followed by incubation with the affinity purified isoform specific
antisera and goat anti-rabbit IgG conjugated with peroxidase, and detection by
ECL. The valuesobtained for the abundance ofthe two proteins in fentomoles/
10
5 or 10
6 cells were then converted in number of molecules/cell.
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was different. These cells only showed a dramatic reduction in
the rate of proliferation 3 days after induction of RNAi, during
which time the cell density increased  20-fold (Figure 5A).
Levels of TbEIF4AIII fell dramatically during the ﬁrst 24 h of
RNAi (Figure 5B), and the protein was only just detectable in
extracts derived from cells at the 48 h time point. It is possible
that, owing to its low abundance even in wild-type cells,
residuals levels of TbEIF4AIII persist longer than 48 h in
the cells after RNAi although they are not detected by the
western blotting assay. These residual levels would be respon-
sible for the delayed onset of the growth phenotype. The
western blotting results also conﬁrm that lack of TbEIF4AIII
is not involved in the phenotype induced by the depletion of
TbEIF4AI since no reduction in levels of TbEIF4AIII was
observed in cells submitted to the TbEIF4AI RNAi procedure
(Figure 5B). Likewise the TbEIF4AIII RNAi does not lead to
any reduction in the levels of TbEIF4AI (Figure 4B). These
results are compatible with TbEIF4AIII being required only at
very low levels so that many cell cycles are required after
addition of tetracycline to impair cell growth. In contrast,
the levels of TbEIF4AI, despite its abundance in wild-type
cells, are much more sensitive to RNAi mediated depletion,
consistent with a role in overall protein synthesis.
Expression of dominant negative mutants of TbEIF4AI
and III in transfected procyclic cells
The helicase activity of eIF4A is essential for protein synthesis
and viability and some mutations that abolish its activity can
Figure 4. RNAi of TbEIF4AI. Procyclic T.brucei cells were transfected with
thep2T7-177derivedplasmidcontainingtheTbEIF4AIgene.Transfectedcells
wereselectedaftergrowthinthepresenceofphleomycinandRNAinterference
induced after tetracycline addition. At regular intervals, cellular growth was
monitored by counting the number of viable cells, expression of TbEIF4AI
assayed and total protein synthesis investigated by [
35S]methionine incorpora-
tion. (A) Cell density of transfected cultures with and without tetracycline
addition.(B)Westernblotanalysisofthetimecourse.Notethevariousdilutions
of total cell extract for comparison (1–1/32 cell equivalent—1 cell equivalent
equals to 10
6 cells and was used in the various RNAi lanes). TbEIF4AI was
detected with the affinity purified antisera and anti-BiP was used as a loading
control. The same blot was probed with both antibodies. Equivalent extracts of
cells transfected with the p2T7-177/TbEIF4AIII construct (see also Figure 5)
were also used in the blot to monitor for TbEIF4AI levels. (C) [
35S]methionine
incorporation profile in transfected cells grown without tetracycline or 24 and
48 h after its addition. Total protein synthesis was estimated after RNAi
forTbEIF4AIbyincubatingaliquotsofthecellsinthepresenceof[
35S]methio-
nine for 1 h followed by TCA precipitation, quantitation of the incorpor-
ated radioactivity or SDS–PAGE followed by autoradiography of the
selected samples.
Figure 3. Subcellular localization of TbEIF4AI and III in T.brucei procyclic
forms. Subcellular localization of the TbEIF4AI and III /EYFP fusion proteins
intransfectedT.bruceicellswasexaminedwithafluorescencemicroscope.The
localization of native TbEIF4AI and III was also confirmed in wild-type pro-
cyclic cells (WT 427) by indirect immunofluorescence using the TbEIF4AI or
TbEIF4AIII specific antibodies followed by incubation with the fluorescein-
conjugatedsecondaryantibody.Whereindicated,thecellswerecounterstained
tolocatethenuclearandkinetoplastDNA.NotelackofTbEIF4AIIIstainingof
the kinetoplast.
2500 Nucleic Acids Research, 2006, Vol. 34, No. 9act as dominant negative mutants. Wild-type T.brucei heli-
cases and equivalent DEAD-box mutant transgenes, in
which the glutamic acid residue in the DEAD motif II
(Figure1)was substitutedwith aglutamine(DEAD!DQAD),
DQAD), were expressed using a tetracycline-inducible pro-
moter. This mutation induces a dominant negative phenotype
in mammalian eIF4AI, resulting in potent inhibition of protein
synthesis and is widely used to abrogate the function of
DEAD-box proteins (11,36). The transgenes encoded a
C-terminal triple myc tag to distinguish the expression of
the transgene from the endogenous protein. Wild-type and
mutant versions of the two proteins were then expressed in
procyclic Lister 427 29-13 cells and analysed by western blot-
ting (Figure 6). The tetracycline regulation of expression was
effective and the wild type and mutant proteins were expressed
at similar levels (Figure 6A). The level of expression relative
to the endogenous protein varied; the expression from the
TbEIF4AI transgenes was lower than expression from the
endogenous gene whereas expression from the TbEIF4AIII
transgenes was several fold higher than the endogenous pro-
tein. All the myc-tagged transgenes localized correctly (data
not shown).
Cell growth and transgene expression was monitored over a
time course (Figure 6B). Expression from the TbEIF4AI trans-
gene reduced over the time course and was barely detectable
by104 h.Wehave observedthisdiminutionofexpressionover
time with other, but not all, transgenes expressed from vectors
derived from pLEW100 and are unsure of the cause. The only
transgenethathadanyeffectongrowth wasthe mutantformof
TbEIF4AI (Figure 6C), all others grew at the same rates as the
control cultures without tetracycline (data not shown). At
18–51 h after the addition of tetracycline, the expression levels
of the TbEIF4AI transgenes were readily detectable and the
mutant, but not the wild type, produced a slowing of growth.
As the expression of the transgene reduced, the culture
returned to the same rate of growth as the no tetracycline
control. In contrast, the signiﬁcantly overexpressed TbEI-
F4AIII mutant transgene had no effect on growth of the cul-
ture. Interestingly, the expression of the TbEIF4AIII
transgenes, but not the TbEIF4AI transgenes, resulted in
increased levels of the endogenous protein. Overall, the results
are compatible with the RNA helicase activity of TbEIF4AI
being strictly required for growth. As for TbEIF4AIII, the lack
of a slow growth phenotype when the dominant negative mut-
ant is expressed suggests that either its RNA helicase activity
is not required for the protein function or it is not affected by
the DEAD!DQAD mutation. Either option strongly indicates
that TbEIF4AIII is not active in translation.
Mapping of isoform specific amino acids
The results described above for TbEIF4AIII are reminiscent of
what is known of mammalian eIF4AIII (Discussion). Human
eIF4AIII, identiﬁed previously asa negative regulator of trans-
lation(22), has been shownto be a component of the EJC,with
roles in mRNA export, cytoplasmic RNA localization and
NMD (24–27). Pairwise sequence comparisons between TbEI-
F4AI and III (or their orthologues in T.cruzi and L.major) and
the functionally divergent human eIF4AI/eIF4AIII do not
show a clear match between either of the parasite homologues
with the two human sequences. Indeed, the overall identity
between human eIF4AI/eIF4AIII (66%) is greater than that
between either protein and the two trypanosomatid eIF4As
( 55–60%).
The kinetoplastid eIF4AI and eIF4AIII sequences were then
aligned with putative eIF4AI and eIF4AIII homologues from
the major lines of eukaryotic evolution (Figure 7). The homo-
logues from Arabidopsis thaliana and Schizosaccharomyces
pombe were identiﬁed using BLAST searches of non-
redundant sequence databases using the human eIF4AI or
eIF4AIII sequences as queries. The alignment in Figure 7
does not show any continuous sequence of amino acids that
distinguish between all putative eIF4AI or eIF4AIII homo-
logues. However, at various positions, interspersed within
the sequences common to both sets of proteins, individual
amino acids can be identiﬁed which are conserved and unique
either to the eIF4AI or eIF4AIII proteins. Table 1 lists 13
positions where a clear difference could be found between
the two sets of sequences. Several, but not all, of these
amino acid substitutionsare alsosharedby aneIF4AIII-related
protein from Saccharomyces cerevisae, Fal1p, a nucleolar
protein shown to be required for 40S ribosomal subunit forma-
tion (45). Fal1p, however, does not seem to be involved in EJC
Figure 5. RNAi of TbEIF4AIII. Procyclic T.brucei cells were transfected with
the p2T7-177/ TbEIF4AIII construct as described for Figure 4, monitored for
cellular growth and assayed for expression of TbEIF4AIII. (A) Cell density of
transfected cultures at different time points with and without tetracycline addi-
tion. (B) Western blot analysis of the time course for both the TbEIF4AIII and
TbEIF4AI RNAi experiments using the TbEIF4AIII antibodies. Samples from
the same experiment assayed in Figure 4B were assayed for TbEIF4AIII
expression.
Nucleic Acids Research, 2006, Vol. 34, No. 9 2501formation since a search in S.cerevisae for similar EJC con-
stituents, conserved in other fungi and in plants, such as
Magoh or Y14, did not produce any clear homologues.
The various amino acid substitutions listed in Table 1
(TbEIF4A I numbering), indicated by a star in the alignment
in Figure 7, discriminate between all putative eIF4AI and
eIF4AIII homologues compared, including the two trypanoso-
matid proteins. These substitutions are located in the two
globular domains present in eIF4A and related DEAD-box
helicases (11,14). Both the N- and the C-terminal domains
have been shown to participate in the binding to RNA and
ATP required for the helicase/ATPase activities, but few roles
have been postulated for them regarding speciﬁc protein func-
tions. The alignment results clearly show that candidate
eIF4AIII homologues are present throughout the various
eukaryotic lineages, although it has only been functionally
characterized in metazoans. The unique substitutions are
also indicative of amino acids involved in speciﬁc aspects
of eIF4AI/III function in general (see below).
Molecular modelling of TbEIF4AI and TbEIF4AIII
To understand the functional implications of the observed
amino acids substitutions to eIF4A function, not only in
Figure 6. Expression of myc-tagged dominant negative mutants of TbEIF4AI and III in procyclic cells. (A) Western blot analysis of the expression of the various
TbEIF4AI andIII/mycfusionsin transfectedcells in theabsenceorafter exposureto tetracyclinefor18h. Ineach casethe expressionwasdetectedusingantibodies
specifictoeach oftheeIF4Ahomologues.TheTbEIF4AIwesternblotwassimultaneouslyprobedwithanti-BiPasaloadingcontrol.(B)Timecourseexpressionof
the different versions of TbEIF4A-myc after tetracycline addition to the culture. The TbEIF4AI western blot was simultaneously probed with anti-BiP as a loading
control. (C) Effect of the expression of the dominant negative form of TbEIF4AI-myc on the growth of the transfected cells in culture.
2502 Nucleic Acids Research, 2006, Vol. 34, No. 9trypanosomatids butalso ineukaryotes in general, we modeled
the structures of both TbEIF4AI and III based on the solved
structure of either the yeast S.cerevisae eIF4A (12) or the
related DEAD-box protein Dhh1p (46). The structure of
yeast eIF4A is in an open conformation with the two globular
domains positioned apart and non-interacting. In contrast,
Dhh1p is in a closed conformation with the two domains
facing each other. Most of the conserved motifs in Dhh1p
are positioned in close spatial proximity facing the cleft
between the two domains. Both sets of models were validated
as described (33) and found to have self-consistency in terms
of sequence–structure compatibility and to be of good overall
quality. For our analysis we favored the closed conformation
structure since the two domains need to interact in order to
fully form the ATP- and RNA-binding sites (12,46,47).
Figure 8A shows the ribbon drawing for the predicted struc-
tures of TbEIF4AI and TbEIF4AIII. Highlighted in the ﬁgure
are severalofthe diagnosticaminoacidsubstitutionsidentiﬁed
in the eIF4A alignment (Figure 7). Of special interest is the
V/L328W substitution in motif V, in the C-terminal domain.
Figure7.SequencealignmentcomparingTbEIF4AIandIIIwiththeputativeeIF4AIandeIF4AIIIfromselectedorganisms.(A)Sequenceswerealignedasdescribed
in Figure 1 and the variousDEAD-box motifs are shown as indicatedpreviously.The predicted secondary structural elements derivedfrom the modellingshown in
Figure 8 and from Ref. (46) are indicated numbered a1–a13/h1–h4 (alpha-helices—H) and b1–b14 (beta-strands—S). Asterisk indicates amino acids which
distinguish between the eIF4AI and eIF4AIII homologues. Further relevant GenBank accession numbers: human (Hs) eIF4AI, AAX43035; human eIF4AIII
(HseIF4A3), P38919; S.pombe (Sp) eIF4A1, CAA56772; S.pombe eIF4A-like protein (Sp4Alike), CAA92238; A.thaliana (At) eIF4A1, NP_177417; A.thaliana
eIF4A-like protein (At4Alike), NP_188610.
Nucleic Acids Research, 2006, Vol. 34, No. 9 2503Motif V lies in a loop positioned in the interface between the
two domains and, in Dhh1p, several amino acids in this motif
are seen to make direct interactions with speciﬁc amino acids
in motifs I and Q, positioned in the N-terminal domain (46). In
the modelsshownhereboththeVandWresiduesinTbEIF4AI
and III, respectively, are protruding from the main polypeptide
backbone in the direction of a cleft in the proteins’ N-terminal
domain. To investigate the likelihood of either amino acid
interacting with neighboring chains, atoms in these chains
were ﬁrst identiﬁed which are positioned within a radius of
4 s from the two residues. These are the only ones capable of
forming non-covalent interactions to atoms in either amino
acid and the full set of potential interactions are shown in
Figure 8B as dotted lines. The substantially larger W residue
in TbEIF4AIII is capable of making a number of interactions
with neighboring amino acids in both the N- and C-terminal
domains, as well as with the polypeptide backbone. In con-
trast, the V residue in TbEIF4AI is very limited in the number
of interactions it can establish. It is possible then that the
presence of the W residue in TbEIF4AIII, and other eIF4AIII
homologues, can enhance the interaction between the helica-
se’s two domainsas compared to the V/Lresidue in the eIF4AI
and even Dhh1p proteins.
Other potentially interesting eIF4AIII-like substitutions
map in helices 5 (Q/R139E/G, Q/A146D/E) and 10 (L256F,
E264D), on the N- and C-terminal domains, respectively.
These helices are largelyexposed to the solvent on the external
side of the proteins (Table 1) and thus the amino acids
involved could mediate eIF4A binding to functional partners.
Indeed, recent evidence strongly supports such a hypothesis.
First, the binding surface for eIF4GII has been mapped to the
C-terminal domain of eIF4AI (47). A double mutation in
human eIF4AI which prevents binding to eIF4GII maps to
helix 10 and targets the same glutamate residue (E264)
found to be unique to the eIF4AI sequences. Likewise, the
two substitutions in helix 5 are included within a proposed
eIF4AIII speciﬁc motif (motif C) which has just been found to
constitute part of the binding site for the EJC component
MNL51 (30). Moreover, a further unique substitution identi-
ﬁed in Figure 7, which lies in an exposed loop near the
C-terminal end of the eIF4A proteins (H/N388A/S—also
shown in Figure 8), lies within another proposed motif
(motif H) found to be required for eIF4AIII to bind spliced
mRNA and to rescue NMD in eIF4AIII depleted cells (30). In
summary, we have identiﬁed several individual amino acids
conserved in either eIF4AI or eIF4AIII sequences which may
play signiﬁcant roles in these proteins’ functions not only in
trypanosomatids but also in eukaryotes in general.
DISCUSSION
The results presented here provide strong supportthat only one
of the two eIF4A homologues identiﬁed in trypanosomatids is
involved in the initiation of translation. The abundance of the
TbEIF4AI protein, its constitutive expression during the para-
site life cycle as well as its cytoplasmic localization, the effect
ofRNAi depletion and the dominantnegative phenotypeof the
DEAD!DQAD mutation are all compatible with what is
expected of this protein. In contrast, TbEIF4AIII does not
seem to play an obvious role in protein synthesis. The nuclear
localization of TbEIF4AIII, its low abundance, longer
responsetothe RNAi inducedphenotypeandlackofinhibition
by the dominant negative mutant all indicate an essential role
in RNA metabolism inthe nucleus unrelated toeIF4A function
in translation. These results are also compatible with what is
known of the L.major orthologues; LmEIF4AI binds strongly
to at least two eIF4G homologues whereas LmEIF4AIII has a
reduced binding activity [(33) and C. R. S. Reis, unpublished
data]. Mammalian eIF4AIII localizes mainly to the nucleus
(23), is present in levels  10-fold lower than eIF4AI in HeLa
cells and does not function in protein synthesis (22). An
unusual feature of human eIF4AIII is that the DEAD!DQAD
DQAD mutation has no effect on its activity in EJC formation
and NMD (30). Thus, TbEIF4AIII behaves similarly to human
eIF4AIII in several important aspects and, coupled with the
sequence analysis data, our results are consistent with it being
an eIF4AIII orthologue with functions possibly conserved
along most major lines of eukaryotic organisms.
As part of the EJC, eIF4AIII binds directly to the core
proteins Magoh, Y14 and MLN51 (25–30) and also to other
proteins required for EJC function such as the TAP and Aly/
REF proteins involved in nuclear mRNA export (25). Magoh
homologues have been clearly identiﬁed in the three try-
panosomatid genomes ﬁnished to date, T.brucei (GenBank,
AAZ12053), T.cruzi (EAN97132) and L.major (CAJ06870)
and possible TAP homologues can also be found. We have
also tried to identify candidate Y14, MLN51 or Aly/REF
Table 1. Summary of the amino acid substitutions identified between the putative eIF4AI/eIF4AIII homologues from the main lineages of eukaryotic evolution
Position: TbEIFAI Substitution: 4AI > 4AIII Secondary structure Domain Overall position in predicted tertiary structure
93 K/N/V > R Loop N-terminal Near a5/exposed
139 Q/R > E/G a 5 N-terminal Exposed
146 Q/A > E/D a 5 N-terminal Exposed
153 V > S/A
a b4 N-terminal Buried
197 F > Y a8 N-terminal Partially exposed
213 M > L Loop N-terminal Interface/next to Motif III/partially buried
220 L/V/I > M a9 N-terminal Buried
226 R/N > T Loop C-terminal Exposed
256 L > F
a a 10 C-terminal Partially buried
264 E > D
a a 10 C-terminal Exposed
303 S/D > P
a Loop C-terminal Exposed
328 V/L > W
a Loop C-terminal Interface/Motif V/Buried
388 H/N > A/S
a Loop C-terminal Exposed
aThese substitutions but not the others are present in the S.cerevisae nucleolar protein Fal1p [may be related to the eIF4AIII proteins (45)].
2504 Nucleic Acids Research, 2006, Vol. 34, No. 9homologues but so far without success. However, both Y14
and Aly/REF are small RNA-binding proteins with single
RRMs, a category which includes many proteins with
unassigned functions in those three genomes (48). It may
be possible that, due to the degree of evolutionary distance
between trypanosomatids and animals, homologues to these
two proteins cannot be clearly identiﬁed by sequence analysis
alone. As for MLN51 it is poorly conserved outside the meta-
zoans so it is unlikely also for homologues to be identiﬁed in
trypanosomatids only by sequence analysis. Nevertheless the
strong conservation of the Magoh sequences between the
human and parasite homologues (over 50% identity) is an
indication that the EJC may be present throughout the
major groups of eukaryotes and that eIF4AIII-like proteins
may be active within this complex.
In a very recent study eight eIF4AIII speciﬁc motifs (named
A to H) were identiﬁed in an alignment comparing various
eIF4AIII homologues with the human eIF4AI and II proteins.
Selected amino acids in some of these motifs, as well as in the
canonical eIF4A motifs I, Ia and VI, were then mutated in
recombinant or in vivo overexpressed eIF4AIII to investigate
their requirement for eIF4AIII function (30). In the alignment
provided here, which includes both T.brucei eIF4A homo-
logues,aswellaseIF4AI sequences fromdivergentorganisms,
no continuous set of amino acids were found to be typical of
either eIF4AI or eIF4AIII proteins. However, unique amino
acid substitutions were identiﬁed which distinguish eIF4AIII-
like proteins from eIF4AI homologues in all sequences inves-
tigated so far. Several of these substitutions not only coincide
with some of the proposed eIF4AIII speciﬁc motifs (motifs C,
E and H), but also are included in two of those motifs found to
be involved in speciﬁc eIF4AIII functions such as binding to
the EJC partner MLN51 (motif C) and requirements for bind-
ing to spliced mRNA and for NMD (motif H) (30). However
some of the unique eIF4AI/eIF4AIII substitutions identiﬁed
here do not coincide with the remaining proposed motifs.
These might be involved in mediating other aspects of
eIF4A function and should be considered as targets for further
investigation.
Very few protein coding genes in trypanosomatids contains
a cis-intron (49,50). However, every cytoplasmic mRNA is
trans-spliced to form the mature 50 end of the mRNA and this
splice siteispossiblythe location ofEJCbinding.Thefunction
of the EJC in these organisms remains obscure specially con-
sidering that the splice site is always to the 50 side of the ORF.
The EJC-mediated mechanism of NMD seems to be restricted
to mammalian cells [reviewed in (51,52)] and indeed there is
strong evidence that NMD does not occur in trypanosomatids
(38). In mammals, both the EJC and the nuclear cap-binding
complex(CBC,composedoftwosubunitsCBP20andCBP80)
Figure 8. MolecularmodellingofTbEIF4AIandIIIhighlightingthepositionof
amino acids unique to the eIF4AI or eIF4AIII homologues. Diagrams were
createdwiththeprogramPyMol(http://www.pymol.org).(A)Ribbondiagrams
oftheoverallstructureofbothTbEIF4AIandIIIviewedasin(46)(upperpanel)
or rotated 180  about its long axis (lower panel). The structure is in a closed
conformationwherethetwo,N-andC-terminal,domainsarefacingeachother.
ThearrowsindicatethepositionoftheL328Wsubstitutionwhichliesintheloop
containing Motif V and is positioned in the interface between the two domains.
Thedottedcirclesdelimitthetwohelicesdiscussedinthetext,a5anda10.The
H/N388A/S andM213Lsubstitutionsare alsoindicated(theirnumbering differ
however from the eIF4AI/eIF4AIII sequences—for instance, H388 in
TbEIF4AI is equivalent to A387 in TbEIF4AIII and so on). (B) Balls and sticks
representation showing the neighbourhood of the L328W substitution in both
TbEIF4AIandIII.Thedottedlinesindicatetheatomsintheneighbouringamino
acid chainswhich are positionedwithina radius of 4 s from the atoms in either
the L or W residues. In both (A and B), the relevant amino acids are listed.
Nucleic Acids Research, 2006, Vol. 34, No. 9 2505bind to precursor mRNAs in the nucleus, prior to or during the
splicing event, and remain bound to the mRNAs until they are
transported to the cytoplasm and/or translated for the ﬁrst time
(53,54). In T.brucei a novel CBC has been described which
consists of a CBP20 subunit (also present inyeast and humans)
plus four other polypeptides, one of which is importin-a
(known to associate with CBC in other eukaryotes) and
three novel proteins only present in trypanosomatids. The
parasite CBC has been implicated in the early steps of
mRNA maturation, prior to the trans-splicing event whereas
the polycistronic precursor mRNA is cleaved into mature
monocistronic units (55). At this stage it still remains to be
determined whether TbEIF4AIII and other components of the
putative EJC are also necessary for mRNA processing, export
from the nucleus or even translation in trypanosomatids.
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